ctHPVDNA Adapted ChemoRadiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer (CHART-AC)
Latest Information Update: 25 Aug 2026
At a glance
- Drugs Capecitabine (Primary) ; Fluorouracil (Primary) ; Retifanlimab (Primary)
- Indications Anal cancer; Squamous cell cancer
- Focus Therapeutic Use
- Acronyms CHART-AC
Most Recent Events
- 26 Jun 2026 Planned initiation date changed from 1 Jun 2026 to 19 Jun 2026.
- 26 Jun 2026 Status changed from not yet recruiting to recruiting.
- 12 Jun 2026 Planned initiation date changed from 1 Mar 2026 to 1 Jun 2026.